SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-056524
Filing Date
2017-11-06
Accepted
2017-11-06 16:06:31
Documents
65
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv477426_10q.htm 10-Q 768556
2 EXHIBIT 10.1 tv477426_ex10-1.htm EX-10.1 16380
3 EXHIBIT 31.1 tv477426_ex31-1.htm EX-31.1 7827
4 EXHIBIT 31.2 tv477426_ex31-2.htm EX-31.2 7753
5 EXHIBIT 32.1 tv477426_ex32-1.htm EX-32.1 4116
  Complete submission text file 0001144204-17-056524.txt   5784883

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT icpt-20170930.xml EX-101.INS 1750117
7 XBRL TAXONOMY EXTENSION SCHEMA icpt-20170930.xsd EX-101.SCH 36428
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE icpt-20170930_cal.xml EX-101.CAL 47517
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE icpt-20170930_def.xml EX-101.DEF 102727
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20170930_lab.xml EX-101.LAB 297861
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20170930_pre.xml EX-101.PRE 251309
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 171179558
SIC: 2834 Pharmaceutical Preparations